LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
Coskun, Tamer, Sloop, Kyle W., Loghin, Corina, Alsina-Fernandez, Jorge, Urva, Shweta, Bokvist, Krister B., Cui, Xuewei, Briere, Daniel A., Cabrera, Over, Roell, William C., Kuchibhotla, Uma, Moyers, JМова:
english
Журнал:
Molecular Metabolism
DOI:
10.1016/j.molmet.2018.09.009
Date:
October, 2018
Файл:
PDF, 2.05 MB
english, 2018
File converter
Більше результатів пошуку
More benefits 
